99 related articles for article (PubMed ID: 18058596)
41. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with Type 2 diabetes previously on long-term conventional insulin therapy: the SWITCH Pilot Study.
Schiel R; Müller UA
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):58-64. PubMed ID: 17973208
[TBL] [Abstract][Full Text] [Related]
42. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.
Janka HU; Plewe G; Busch K
J Am Geriatr Soc; 2007 Feb; 55(2):182-8. PubMed ID: 17302653
[TBL] [Abstract][Full Text] [Related]
43. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
Janka HU; Plewe G; Riddle MC; Kliebe-Frisch C; Schweitzer MA; Yki-Järvinen H
Diabetes Care; 2005 Feb; 28(2):254-9. PubMed ID: 15677775
[TBL] [Abstract][Full Text] [Related]
44. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the Switch pilot study.
Schiel R; Müller UA
Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):627-33. PubMed ID: 18058596
[TBL] [Abstract][Full Text] [Related]
47. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
48. Effects of three injectable antidiabetic agents on glycaemic control, weight change and drop-out in type 2 diabetes suboptimally controlled with metformin and/or a sulfonylurea: A network meta-analysis.
Zhong X; Zhang T; Liu Y; Wei X; Zhang X; Qin Y; Jin Z; Chen Q; Ma X; Wang R; He J
Diabetes Res Clin Pract; 2015 Sep; 109(3):451-60. PubMed ID: 26233934
[TBL] [Abstract][Full Text] [Related]
49. Basal insulin treatment in type 2 diabetes.
Hedrington MS; Pulliam L; Davis SN
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1(Suppl 1):S33-42. PubMed ID: 21668335
[TBL] [Abstract][Full Text] [Related]
50. Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.
Raccah D
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():76-82. PubMed ID: 18577159
[TBL] [Abstract][Full Text] [Related]
51. Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience.
Schreiber SA
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():24-34. PubMed ID: 18577154
[TBL] [Abstract][Full Text] [Related]
52. Basal insulin supplementation in type 2 diabetes; refining the tactics.
Rosenstock J
Am J Med; 2004 Feb; 116 Suppl 3A():10S-16S. PubMed ID: 15013455
[TBL] [Abstract][Full Text] [Related]
53. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
Qayyum R; Bolen S; Maruthur N; Feldman L; Wilson LM; Marinopoulos SS; Ranasinghe P; Amer M; Bass EB
Ann Intern Med; 2008 Oct; 149(8):549-59. PubMed ID: 18794553
[TBL] [Abstract][Full Text] [Related]
54. [LAPTOP trial--results of an health economics evaluation].
Dippel FW
Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S115-9; discussion S124-6. PubMed ID: 18686220
[TBL] [Abstract][Full Text] [Related]
55. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
[TBL] [Abstract][Full Text] [Related]
56. Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease.
Hermansen K; Mortensen LS; Hermansen ML
Vasc Health Risk Manag; 2008; 4(3):561-74. PubMed ID: 18827907
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
